case report aspiration anesthesia semaglutide 2023 during What happened in medicine this week has real consequences in GLP-1 Agonists and the Risk – Semaglutide: Shedding pounds, weighing risks

2-deoxy-2-[fluorine-18] fluoro-d-glucose ([18 F]-FDG) (Dongcheng AMS Pharmaceutical atom, Shanghai, China) was injected into the tail vein at a dose of ~3.7 MBq/10 g body weight (0.1 mCi/10 g)

Online conversations help users understand they arent alone in dealing with side effects, yet medical evidence is still necessary to confirm if theres a real link between semaglutide and yeast infections

Why accept 15% weight loss when 25% might eventually be on offer

So, when does it matter

I was skeptical to say the least

One problem with this method in general is that the sample, when presented, is a poor reflection of the real changes in odour that have taken place during the time in which it was collected (a similar point has been made to use of static facial images in visual communication: Jack & Schyns, Reference Jack and Schyns2015)